ProstaLund

Less than 1K followers

Overview

Investor consensus

All

Press releases

3rd party

ShowingAll content types

Regulatory press release10/24/2025, 5:30 AM

PROSTALUND AB (publ) - Interim report January-September 2025

Press release9/12/2025, 6:00 AM

ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman

Press release9/10/2025, 6:00 AM

ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release8/21/2025, 5:30 AM

ProstaLund AB - Interim Report January-June 2025

Press release6/26/2025, 2:45 PM

First CoreTherm® Eagle treatments performed in Denmark

Press release6/17/2025, 8:00 AM

Second clinic in Sweden starts treatment with CoreTherm® Eagle

Regulatory press release5/30/2025, 5:30 AM

ProstaLund AB - Interim report January-March 2025

Press release5/20/2025, 1:50 PM

First patients treated with CoreTherm® Eagle

Press release5/14/2025, 8:45 AM

First treatments with CoreTherm® Eagle to be performed next week – Key milestone for ProstaLund

Press release2/24/2025, 2:00 PM

Correction: Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

Press release2/24/2025, 8:05 AM

Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

Regulatory press release2/20/2025, 6:30 AM

ProstaLund AB - Year-end report 2024

Press release2/14/2025, 2:45 PM

New study confirms the strong efficacy of CoreTherm® in patients with large prostates

Press release1/27/2025, 9:00 AM

Elderly men treated with CoreTherm® for benign prostatic hyperplasia have lower risk for a prostate cancer diagnosis later in life compared to men treated with TURP, according to a new Swedish register study

Press release12/10/2024, 8:00 AM

Additional study published confirming effectiveness of transurethral intraprostatic anaesthesia (TUIA) using our Schelin Catheter® during benign prostatic enlargement treatments

Third party research11/11/2024, 12:11 PM

ProstaLund: CoreTherm Eagle flygfärdig - VH Corp

* Tio CoreTherm Eagle-maskiner är tillverkade * Förbättrat patientflöde jämfört med första halvåret * Vi behåller vårt motiverade värde om 0,81 SEK per aktie ProstaLunds nettoomsättning i Q3 om 3,5 MSEK var klart lägre jämfört med samma period 2023. ...

Press release11/7/2024, 11:00 AM

The first ten CoreTherm® Eagle machines are manufactured

Regulatory press release11/7/2024, 6:30 AM

Interim report January-September 2024

Press release10/11/2024, 8:00 AM

Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE

Press release10/4/2024, 11:00 AM

First published report of transurethral intraprostatic anaesthesia (TUIA) using the Schelin Catheter® in patients undergoing holmium laser enucleation of the prostate

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.